Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019004970) HETEROBIVALENT LIGANDS SUITABLE FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/004970 International Application No.: PCT/TR2018/050166
Publication Date: 03.01.2019 International Filing Date: 14.04.2018
IPC:
A61K 38/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
Applicants:
T.C. İSTANBUL MEDİPOL ÜNİVERSİTESİ [TR/TR]; Kavacık Mah. Ekinciler Cd. No:19 Istanbul, TR
BAHÇEŞEHİR ÜNİVERSİTESİ [TR/TR]; Yıldız Mh. Çırağan Cd. 34349 Beşiktaş/İstanbul, TR
Inventors:
ŞENSOY, Özge; TR
GÜZEL, Mustafa; TR
KERMAN, Bilal Ersen; TR
ÜSTÜNDAĞ OKUR, Neslihan; TR
MANSOOR, Samman; TR
ALSHAHABY, Essam; TR
KESKİN, Elif; TR
DURDAĞI, Serdar; TR
KAYIK, Gülru; TR
Agent:
ŞİMŞEK, Meliha Merve; TR
Priority Data:
TR 2017/0570018.04.2017TR
Title (EN) HETEROBIVALENT LIGANDS SUITABLE FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE
(FR) LIGANDS HÉTÉROBIVALENTS POUVANT ÊTRE UTILISÉS DANS LE TRAITEMENT DE LA MALADIE DE PARKINSON
Abstract:
(EN) The present invention relates to the use of novel drug molecules and,use of said novel drug molecules in the treatment of neurodegenerative diseases, such as Parkinson's disease.
(FR) La présente invention concerne l'utilisation de nouvelles molécules médicamenteuses, notamment l'utilisation de ces nouvelles molécules médicamenteuses dans le traitement de maladies neurodégénératives, telles que la maladie de Parkinson.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: ???LANGUAGE_SYMBOL_TR??? (TR)